Zha J - Search Results

1

The STAT1/HMGB1/NF-κB pathway in chronic inflammation and kidney injury after cisplatin exposure.

Fu Y, Xiang Y, Wang Y, Liu Z, Yang D, Zha J, Tang C, Cai J, Chen G, Dong Z. Fu Y, et al. Among authors: zha j. Theranostics. 2023 May 8;13(9):2757-2773. doi: 10.7150/thno.81406. eCollection 2023. Theranostics. 2023. PMID: 37284446 Free PMC article.

2

Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway.

Chen H, Tan C, Wang Z, Zha J, Liu H, Dong Z, Chen G. Chen H, et al. Among authors: zha j. Biochem Pharmacol. 2023 May;211:115503. doi: 10.1016/j.bcp.2023.115503. Epub 2023 Mar 15. Biochem Pharmacol. 2023. PMID: 36924904

3

Activation of CD3 + TIM3 + T cells contributes to excessive inflammatory response during glucocorticoid treatment.

Liu Z, Chen H, Tan C, Zha J, Liu H, Chen G. Liu Z, et al. Among authors: zha j. Biochem Pharmacol. 2023 Jun;212:115551. doi: 10.1016/j.bcp.2023.115551. Epub 2023 Apr 10. Biochem Pharmacol. 2023. PMID: 37044297

4

T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases.

Chen H, Zha J, Tang R, Chen G. Chen H, et al. Among authors: zha j. Int Immunopharmacol. 2023 Aug;121:110418. doi: 10.1016/j.intimp.2023.110418. Epub 2023 Jun 6. Int Immunopharmacol. 2023. PMID: 37290326 Review.

5

The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease.

Chen G, Zeng M, Liu Z, Zhou M, Zha J, Zhang L, Chen H, Liu H. Chen G, et al. Among authors: zha j. Int Immunopharmacol. 2023 Sep;122:110589. doi: 10.1016/j.intimp.2023.110589. Epub 2023 Jul 5. Int Immunopharmacol. 2023. PMID: 37418986

6

Glucocorticoid regulation of the mTORC1 pathway modulates CD4⁺ T cell responses during infection.

Chen H, Liu Z, Zha J, Zeng L, Tang R, Tang C, Cai J, Tan C, Liu H, Dong Z, Chen G. Chen H, et al. Among authors: zha j. Clin Transl Immunology. 2023 Aug 29;12(8):e1464. doi: 10.1002/cti2.1464. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37649974 Free PMC article.

7

Enhanced STAT3/PIK3R1/mTOR signaling triggers tubular cell inflammation and apoptosis in septic-induced acute kidney injury: implications for therapeutic intervention.

Fu Y, Xiang Y, Zha J, Chen G, Dong Z. Fu Y, et al. Among authors: zha j. Clin Sci (Lond). 2024 Mar 20;138(6):351-369. doi: 10.1042/CS20240059. Clin Sci (Lond). 2024. PMID: 38411015

8

A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney disease.

Chen XJ, Tang R, Zha J, Zeng L, Zhou L, Liu Z, Yang D, Zeng M, Zhu X, Chen A, Liu H, Chen H, Chen G. Chen XJ, et al. Among authors: zha j. Front Immunol. 2024 May 15;15:1365226. doi: 10.3389/fimmu.2024.1365226. eCollection 2024. Front Immunol. 2024. PMID: 38812511 Free PMC article.

9

Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development.

Chen H, Song J, Zeng L, Zha J, Zhu J, Chen A, Liu Y, Dong Z, Chen G. Chen H, et al. Among authors: zha j. Biochem Pharmacol. 2024 Nov;229:116505. doi: 10.1016/j.bcp.2024.116505. Epub 2024 Aug 23. Biochem Pharmacol. 2024. PMID: 39181336

10

Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia.

Duan H, Lai Q, Jiang Y, Yang L, Deng M, Lin Z, Shan W, Zhong M, Yao J, Zhang L, Xu B, Zha J. Duan H, et al. Among authors: zha j. Exp Hematol Oncol. 2024 Dec 18;13(1):121. doi: 10.1186/s40164-024-00589-1. Exp Hematol Oncol. 2024. PMID: 39696470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters